← Eichor
Study identifier: NCT06626386 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)

Condition: Prostate Cancer  ·  Sponsor: Heinrich-Heine University, Duesseldorf

PhaseN/A
Planned participants200
Who can joinMale, 45 Years to 70 Years
Healthy volunteersNo

About this study

The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients. Furthermore, a stability test of the samples is carried out after storage at room temperature for 24, 72/96 and 168 hours. Particular attention is paid to the comparability of the measurement results and the influence of the transportation time.

This description comes directly from the study's public registry record.

Talk to the study team

Martin Wallisch  ·  +49 015751187144  ·  martin.wallisch@med.uni-duesseldorf.de

Always discuss trial participation with your own doctor first.

Locations (1)

Klinik für Urologie, Universitätsklinikum DüsseldorfDüsseldorf, North Rhine-Westphalia, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06626386